BR9707785A - Parapoxvírus que contém dna estrangeiro preparação dos mesmos e uso dos mesmos em vacinas - Google Patents

Parapoxvírus que contém dna estrangeiro preparação dos mesmos e uso dos mesmos em vacinas

Info

Publication number
BR9707785A
BR9707785A BR9707785A BR9707785A BR9707785A BR 9707785 A BR9707785 A BR 9707785A BR 9707785 A BR9707785 A BR 9707785A BR 9707785 A BR9707785 A BR 9707785A BR 9707785 A BR9707785 A BR 9707785A
Authority
BR
Brazil
Prior art keywords
vaccines
parapoxvirus
foreign dna
dna preparation
containing foreign
Prior art date
Application number
BR9707785A
Other languages
English (en)
Inventor
Norbert Schmeer
Walter Strube
Mathias Buettner
Hans-Joachim Rziha
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19639601A external-priority patent/DE19639601A1/de
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of BR9707785A publication Critical patent/BR9707785A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24211—Parapoxvirus, e.g. Orf virus
    • C12N2710/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24211—Parapoxvirus, e.g. Orf virus
    • C12N2710/24241—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR9707785A 1996-02-28 1997-02-17 Parapoxvírus que contém dna estrangeiro preparação dos mesmos e uso dos mesmos em vacinas BR9707785A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19607458 1996-02-28
DE19639601A DE19639601A1 (de) 1996-02-28 1996-09-26 Parapockenviren, die Fremd-DNA enthalten, ihre Herstellung und ihre Verwendung in Impfstoffen
DE9700729 1997-02-17

Publications (1)

Publication Number Publication Date
BR9707785A true BR9707785A (pt) 1999-07-27

Family

ID=26023280

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9707785A BR9707785A (pt) 1996-02-28 1997-02-17 Parapoxvírus que contém dna estrangeiro preparação dos mesmos e uso dos mesmos em vacinas

Country Status (19)

Country Link
US (1) US6365393B1 (pt)
EP (1) EP0886679B1 (pt)
JP (1) JP2000507092A (pt)
CN (1) CN1217027A (pt)
AT (1) ATE364090T1 (pt)
AU (1) AU718141B2 (pt)
BR (1) BR9707785A (pt)
CA (1) CA2247336C (pt)
DE (1) DE59712852D1 (pt)
DK (1) DK0886679T3 (pt)
ES (1) ES2287949T3 (pt)
HU (1) HUP9901035A3 (pt)
IL (1) IL125797A0 (pt)
NO (1) NO983946L (pt)
NZ (1) NZ331556A (pt)
PL (1) PL190401B1 (pt)
SK (1) SK120098A3 (pt)
TR (1) TR199801702T2 (pt)
WO (1) WO1997032029A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000507449A (ja) * 1996-03-29 2000-06-20 ユニバーシティ オブ オタゴ パラポックスウイルスベクター
ES2389387T3 (es) * 1998-03-17 2012-10-25 Genentech, Inc. Polipéptidos homólogos de VEGF y de BMP1
US6541008B1 (en) * 1998-11-02 2003-04-01 University Of Otago Vascular endothelial growth factor-like protein from orf viruses binds and activates mammalian VEGF receptor-2, and uses thereof
SI21122A (sl) * 2000-07-11 2003-08-31 Bayer Aktiengesellschaft Uporaba sevov parapoksvirusa ovis za proizvodnjo antivirusnih zdravil in zdravil proti raku
AU2002362072A1 (en) 2001-12-07 2003-06-23 Board Of Regents The University Of Texas System Use a parapox b2l protein to modify immune responses to administered antigens
US6752995B2 (en) * 2002-04-15 2004-06-22 Board Of Regents, The University Of Texas System Nucleic acid and polypeptide sequences useful as adjuvants
DE602005016552D1 (de) * 2004-07-13 2009-10-22 Aicuris Gmbh & Co Kg Parapocken-viren in kombination mit anderen antiviralen mitteln zur behandlung von hiv/aids
CN102892428A (zh) 2010-04-29 2013-01-23 里姆瑟药物股份公司 表达兔出血热病毒的vp60主要衣壳蛋白的副痘病毒
EP2571521A1 (en) * 2010-05-21 2013-03-27 Ah Usa 42 Llc Parapoxvirus vectors containing rabies virus antigen
WO2012011045A1 (en) * 2010-07-20 2012-01-26 Pfizer Inc. Parapoxvirus vectors
CN104854128A (zh) 2012-07-19 2015-08-19 硕腾有限责任公司 牛流感病毒组合物
AU2013295770A1 (en) 2012-07-27 2015-01-29 Zoetis Services Llc Tick toxin compositions
DE102015111756A1 (de) 2015-07-20 2017-01-26 Eberhard Karls Universität Tübingen Medizinische Fakultät Rekombinanter Orf-Virus-Vektor
BR112018002919B1 (pt) 2015-08-14 2024-02-27 Zoetis Services Llc Composição imunogênica eficaz compreendendo uma cepa de mycoplasma bovis e usos da mesma para prevenção de doenças causadas por mycoplasma bovis
WO2017165366A1 (en) 2016-03-21 2017-09-28 South Dakota Board Of Regents Orf virus-based platform for vaccine delivery
WO2019170820A1 (en) 2018-03-07 2019-09-12 Transgene Parapoxvirus vectors
WO2024062098A1 (en) 2022-09-23 2024-03-28 Transgene Recombinant pseudocowpox virus encoding an interleukin-12

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4405841C1 (de) * 1994-02-23 1995-01-05 Mayr Anton Prof Dr Med Vet Dr Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
AU694519B2 (en) * 1994-04-29 1998-07-23 Immuno Aktiengesellschaft Recombinant poxviruses with foreign polynucleotides in essential regions

Also Published As

Publication number Publication date
US6365393B1 (en) 2002-04-02
IL125797A0 (en) 1999-04-11
PL328870A1 (en) 1999-03-01
EP0886679A1 (de) 1998-12-30
PL190401B1 (pl) 2005-12-30
NO983946L (no) 1998-10-22
HUP9901035A3 (en) 2001-01-29
NZ331556A (en) 2000-05-26
CA2247336C (en) 2008-06-17
EP0886679B1 (de) 2007-06-06
DK0886679T3 (da) 2007-09-24
TR199801702T2 (xx) 1998-12-21
AU718141B2 (en) 2000-04-06
CA2247336A1 (en) 1997-09-04
NO983946D0 (no) 1998-08-27
HUP9901035A2 (hu) 1999-07-28
SK120098A3 (en) 1999-03-12
JP2000507092A (ja) 2000-06-13
CN1217027A (zh) 1999-05-19
WO1997032029A1 (de) 1997-09-04
AU1725797A (en) 1997-09-16
ES2287949T3 (es) 2007-12-16
DE59712852D1 (de) 2007-07-19
ATE364090T1 (de) 2007-06-15

Similar Documents

Publication Publication Date Title
DK0835133T3 (da) Rekombinant koppevirus-rabies-præparater og kombinationspræparater samt anvendelser deraf
NO983946D0 (no) Parapoksyviruser inneholdende fremmed DNA, fremstilling og anvendelse derav i vaksiner
NO20013701L (no) HER-2/neu-fusjonsproteiner
BR0014282A (pt) Vacinas
DE69942708D1 (de) Virus enthaltende Zusammensetzungen und Methoden zur Konzentration von Viruspräparaten
WO1998013500A3 (en) Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
BRPI9912663B1 (pt) vacina contra cáncer e polipeptìdeo.
NO944377D0 (no) Kjölemiddelblandinger
FI962799A7 (fi) Nukleiinihappoja sisältävä valmiste, sen valmistus ja käyttö
NO20001768D0 (no) Viruskapsomervaksine, fremgangsmåte til fremstilling samt anvendelse derav
FI973363L (fi) Nukleiinihappoja sisältävä koostumus, sen valmistus ja käyttö
FI943512A0 (fi) Ihmisen seerumialbumiini, valmistus ja käyttö
BRPI0309631A2 (pt) vacina tetravalente da dengue contendo uma trivial deleção de 30 nucleotídeos na utr-31' dos tipos de dengue 1,2,3,e 4, ou de vírus antigênicos quiméricos da dengue 1,2,3 e 4
BR9807873A (pt) Vacinas de flavivìrus quiméricos
TR200100056T2 (tr) Nörotrofik faktörler
FI925574A7 (fi) Cerium(IV)oksidiin perustuva koostumus, sen valmistus ja sen käyttö
FI960977L (fi) Bakteeriperäiset eksportoidut proteiinit ja niihin perustuvat asellulaariset rokotteet
DK0704499T3 (da) Højtransparente, gule jernoxidpigmenter, fremgangsmåde til deres fremstilling samt deres anvendelse
YU36698A (sh) Parapoks-virusi koji sadrže stranu dnk, njihovo dobijanje i njihova primena u vakcinama
AU1815899A (en) Method and composition to enhance the efficacy of a vaccine using chemokines
ATE319833T1 (de) Impfstoffe zur erhöhung der immunantworten gegen herpes simplex virus
FI970097L (fi) Proteiinit, jotka ovat peräisin nisäkkäiden maksasta ja niiden käyttö onkologiassa
DE69401437D1 (de) Verbesserte schutzmembrane, insbesondere zur verkleidung von wänden und decken
DE69736779D1 (de) Zusammensetzungen von rekombinanten papillomavirus vakzinen
DK0704498T3 (da) Særdeles højtransparente, gule jernoxidpigmenter, fremgangsmåde til deres fremstilling samt deres anvendelse

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B25A Requested transfer of rights approved

Owner name: BAYER HEALTHCARE AG (DE)

Free format text: TRANSFERIDO DE: BAYER AKITIENGESELLSCHAFT

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE COMO INVENCAO - DE ACORDO COM O ART. 8O DA LPI.